Bromide

Bromide

SCHEMBL1502745

CC[n+]1ccc(C)cc1.[Br-]

nearest known ligand 0.54

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CHKA known ✓ P35790 1/20 0.52
ACHE known ✓ P22303 5/20 0.37
HTT P42858 1/20 0.54
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
BCHE P06276 4/20 0.37
TDP1 Q9NUW8 1/20 0.37
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36
RAB9A P51151 1/20 0.36
TP53 P04637 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2D6 P10635 1/20 0.34
MAPT P10636 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
TERT O14746 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL62492 0.97
Water SCHEMBL2149413 0.94 HTT (0.54) HTTCHKAMEN1KMT2AACHE
Hydrochloric Acid SCHEMBL1502838 0.94 HTT (0.54) HTTCHKAMEN1KMT2AACHE
Fluoride Ion SCHEMBL1502900 0.94 HTT (0.54) HTTCHKAMEN1KMT2AACHE
Iodide SCHEMBL1502806 0.94 HTT (0.54) HTTCHKAMEN1KMT2AACHE
SCHEMBL30329823 0.90 HTT (0.50) HTTCHKAMEN1KMT2AACHE
SCHEMBL2150124 0.87 HTT (0.48) HTTCHKAMEN1KMT2AACHE
Diethylamine SCHEMBL8857628 0.87 HTT (0.44) HTTCHKAMEN1KMT2AACHE
SCHEMBL16699884 0.84 HTT (0.45) HTTCHKAMEN1KMT2AACHE
Perchlorate SCHEMBL2150468 0.84 HTT (0.45) HTTCHKAMEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 99 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114566723-B Electrolyte for rechargeable electrochemical cells EOS能源技术控股有限责任公司 2025-03-04 CN claimed
EP-4315482-A1 HALOGEN COMPLEXING AGENTS BOUND TO THE CATHODE SURFACE IN A STATIC ZINC HALIDE BATTERY EOS Energy Technology Holdings, LLC (US) 2024-02-07 EP claimed
EP-3204977-B1 ELECTROLYTE FOR RECHARGEABLE ELECTROCHEMICAL CELL EOS ENERGY TECH HOLDINGS LLC (US) 2023-12-20 EP claimed
WO-2022212163-A1 HALOGEN COMPLEXING AGENTS BOUND TO THE CATHODE SURFACE IN A STATIC ZINC HALIDE BATTERY EOS ENERGY STORAGE LLC (US) 2022-10-06 WO claimed
US-20220320514-A1 HALOGEN COMPLEXING AGENTS BOUND TO THE CATHODE SURFACE IN A STATIC ZINC HALIDE BATTERY EOS ENERGY STORAGE LLC (US) 2022-10-06 US claimed
CN-114566723-A Electrolyte for rechargeable electrochemical cells EOS能源储存有限责任公司 2022-05-31 CN claimed
CN-114436286-A Molecular sieve with TON structure and preparation method and application thereof 中国石油化工股份有限公司 2022-05-06 CN claimed
US-11211607-B2 Bipolar electrode comprising a loaded carbon felt EOS ENERGY STORAGE LLC (US) 2021-12-28 US claimed
US-20200388844-A1 BIPOLAR ELECTRODE COMPRISING A LOADED CARBON FELT CITIBANK, N.A., AS COLLATERAL AGENT 2020-12-10 US claimed
US-20190198881-A1 ELECTROLYTE FOR RECHARGEABLE ELECTROCHEMICAL CELL EOS ENERGY STORAGE LLC 2019-06-27 US claimed
US-10276872-B2 Electrolyte for rechargeable electrochemical cell EOS ENERGY STORAGE, LLC (US) 2019-04-30 US claimed
US-20180013185-A1 ELECTROLYTE FOR RECHARGEABLE ELECTROCHEMICAL CELL EOS ENERGY STORAGE LLC 2018-01-11 US claimed
EP-3204977-A1 ELECTROLYTE FOR RECHARGEABLE ELECTROCHEMICAL CELL Eos Energy Storage, LLC (US) 2017-08-16 EP claimed
US-20170194666-A1 ELECTROLYTE FOR RECHARGEABLE ELECTROCHEMICAL CELL CITIBANK, N.A., AS COLLATERAL AGENT 2017-07-06 US claimed
US-20260042123-A1 DEVICE, METHOD AND COMPUTER PROGRAM FOR PROCESSING OF A SURFACE OF A SUBSTRATE ZEISS CARL SMT GMBH (DE) 2026-02-12 US disclosed
EP-4612750-A1 MIXED POLYHALIDE ELECTROLYTES FOR A STATIC BATTERY AND A METHOD FOR FABRICATING A STATIC BATTERY CELL EOS Energy Technology Holdings, LLC (US) 2025-09-10 EP disclosed
CN-120153514-A Hybrid polyhalide electrolyte for static cells and method for manufacturing static cells EOS能源技术控股有限公司 2025-06-13 CN disclosed
EP-0404188-A1 Non-aqueous electrolytic aluminum plating bath composition NISSHIN STEEL CO., LTD. (JP) 1990-12-27 EP disclosed
EP-0339535-A1 Plating bath for electrodeposition of aluminum and plating process making use of the bath NISSHIN STEEL CO., LTD. (JP) 1989-11-02 EP disclosed
US-4228230-A Ultrasonic imaging of internally fogged silver halide elements EASTMAN KODAK COMPANY (US) 1980-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260042123-A1 DEVICE, METHOD AND COMPUTER PROGRAM FOR PROCESSING OF A SURFACE OF A SUBSTRATE PIEZO1, EPCAM, PLAUR CHKA 3527/4885ACHE 2113/4885HTT 4166/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.